scholarly journals Test-retest reliability of six minute walk test in spastic ambulatory children with cerebral palsy

2014 ◽  
Vol 1 (1) ◽  
pp. 10
Author(s):  
Rutvee Vinchhi ◽  
Shraddha Diwan ◽  
Sweety Shah ◽  
Neeta Vyas
2021 ◽  
Vol 18 (11) ◽  
Author(s):  
Asfarina ZANUDIN ◽  
Yen Yun KHONG ◽  
Ling Fong CHONG ◽  
Nor Azizah MOHAMAD

This study explored the test-retest reliability and construct validity of a two-minute walk test in children and adolescents with CP Gross Motor Function Classification System (GMFCS) levels I, II, and III. Twenty-six participants with CP (age 11.7 ± 3.9 years) were recruited and were assessed twice with the two-minute walk test to determine the test-retest reliability (interval 2 weeks). Minimal detectable changes (MDC95) were calculated. Construct validity was established by comparing the results of the two- and six-minute walk tests during the first assessment. The test-retest reliability was excellent, with intra-class correlation (ICC) = 0.98 for all participants. The (MDC95) for all participants was 12.7 m. The distance covered by children and adolescents with CP in the two-minute walk test had high correlation (r = 0.9, p < 0.01) with distance covered in the six-minute walk test. The two-minute walk test is a valid and reliable outcome measure to assess walking performance in children and adolescents with CP. HIGHLIGHTS The two-minute walk test has excellent reliability and validity among young people with cerebral palsy The minimal detectable change of two-minute walk test among young people with cerebral palsy was 12.7 m The two-minute walk test had high correlation with the six-minute walk test among young people with cerebral palsy


2019 ◽  
Vol 7 (02) ◽  
pp. 18
Author(s):  
Budiati Laksmitasari ◽  
Luh Karunia Wahyuni ◽  
Tirza Z Tamin

Introduction: Children with cerebral palsy (CP), six-minute walk test (6MWT) is more difficult to perform because some children have communication impairment. The objective to study the distance of 6MWT among different level of communication in children with CP.Methods: This study was cross-sectional study , in a Rehabilitation Clinic, on Juli to December 2018. The subjects were children aged 7-18 years old with cerebral palsy with Gross Motor Function Classification System (GMFCS) I-III, Communication Function Classification System (CFCS) I-III, able to walkindependently with or without aid, and understand the instruction of 6MWT. All the subjects performed 6MWT. Level of communication function was evaluated by CFCS. The 6MWD between CFCS groups were compared.Results: There were 23 subjects mean aged 9 years old, consisted of 17(73.9%) male and 6(26.1%) female, with GMFCS level I-III in sequence were 3(13%), 11(47.8%), and 9(39.1%), also with CFCS level I-III in sequence were 5(21.7%), 7(30.4%), and 11(47.8%). Subjects with verbal communicationwere 14(60.9%) and nonverbal communication were 9(39.1%). The median of 6MWD in group with CFCS level I, II, and III respectively were 115 (60-282), 161 (17.5-281), and 135 (23-280) m. There was no significant difference in 6MWD between different groups of CFCS (p=0.960).Conclusion: There were no difference in walking distance on 6MWT among different level of communication function in children with CP.Keywords: Cerebral palsy, Six-minute walk-test, Six-minute walking-distance, Communication Function Classification System (CFCS)


2009 ◽  
Vol 89 (6) ◽  
pp. 569-579 ◽  
Author(s):  
Julie D. Ries ◽  
John L. Echternach ◽  
Leah Nof ◽  
Michelle Gagnon Blodgett

Background: With the increasing incidence of Alzheimer disease (AD), determining the validity and reliability of outcome measures for people with this disease is necessary. Objective: The goals of this study were to assess test-retest reliability of data for the Timed “Up & Go” Test (TUG), the Six-Minute Walk Test (6MWT), and gait speed and to calculate minimal detectable change (MDC) scores for each outcome measure. Performance differences between groups with mild to moderate AD and moderately severe to severe AD (as determined by the Functional Assessment Staging [FAST] scale) were studied. Design: This was a prospective, nonexperimental, descriptive methodological study. Methods: Background data collected for 51 people with AD included: use of an assistive device, Mini-Mental Status Examination scores, and FAST scale scores. Each participant engaged in 2 test sessions, separated by a 30- to 60-minute rest period, which included 2 TUG trials, 1 6MWT trial, and 2 gait speed trials using a computerized gait assessment system. A specific cuing protocol was followed to achieve optimal performance during test sessions. Results: Test-retest reliability values for the TUG, the 6MWT, and gait speed were high for all participants together and for the mild to moderate AD and moderately severe to severe AD groups separately (intraclass correlation coefficients ≥.973); however, individual variability of performance also was high. Calculated MDC scores at the 90% confidence interval were: TUG=4.09 seconds, 6MWT=33.5 m (110 ft), and gait speed=9.4 cm/s. The 2 groups were significantly different in performance of clinical tests, with the participants who were more cognitively impaired being more physically and functionally impaired. Limitations: A single researcher for data collection limited sample numbers and prohibited blinding to dementia level. Conclusions: The TUG, the 6MWT, and gait speed are reliable outcome measures for use with people with AD, recognizing that individual variability of performance is high. Minimal detectable change scores at the 90% confidence interval can be used to assess change in performance over time and the impact of treatment.


Sign in / Sign up

Export Citation Format

Share Document